Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0510717120931463 0.0463085472347182 0.0349298756284731 0.0349298756284731
Stock impact report

AstraZeneca's combo lung cancer treatment fails late-stage study main goal [Reuters (UK)]

AstraZeneca PLC - American Depositary Shares (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
Company Research Source: Reuters
AstraZeneca's combo lung cancer treatment fails late-stage study main goal - Reuters 1 Min Read (Reuters) - AstraZeneca Plc said on Tuesday its combo treatment for a form of lung cancer failed to meet the main goal of improving overall survival in patients in a late stage study. The study tested the combination of Imfinzi and tremelimumab as a first-line treatment in patients with extensive-stage small cell lung cancer, the company said. Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D'Silva All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2020 Reuters. All Rights Reserved. Show less Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AZN alerts

from News Quantified
Opt-in for
AZN alerts

from News Quantified